CMS Releases Extensive Updated FAQs on Medicare COVID-19 Billing and Documentation Issues and Cares Act Provisions

Maynard Nexsen
Contact

Nexsen Pruet, PLLC

On August 26, 2020, the Centers for Medicare & Medicaid Services (CMS) released extensive COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service Billing and certain provisions of the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act). The new FAQs are available here.

The new FAQs are intended to supplement previously released FAQs concerning Emergency and Disaster-Related Policies and Procedures that could only be implemented with a Section 1135 Waiver (statutory authority that allows the Secretary of the Department of Health and Human Services to waive or modify certain Medicare, Medicaid, CHIP, or HIPAA requirements). The FAQs previously released in March, 2019 are available here. CMS noted that in many instances the older FAQs have since been superseded by COVID-specific legislation, emergency rules, and waivers granted under Section 1135.

Topics covered in the new FAQs published August 26, 2020 include:

  • Payment for Specimen Collection for Purposes of COVID-19 Testing
  • Diagnostic Laboratory Services
  • Hospital Services, Hospital PPS Payments under the CARES Act, Hospital Outpatient Locations and Temporary Expansion Locations
  • Ambulance Services
  • Rural Health Clinics and Federally Qualified Health Centers
  • Medicare Telehealth
  • Physician Services
  • Scope of Practice
  • Additional Flexibility under the Teaching Physician Regulations
  • Cost Reporting
  • Opioid Treatment Programs
  • Inpatient Rehabilitation Facilities
  • Skilled Nursing Facilities
  • Home Health
  • National Coverage Determinations
  • Oxygen
  • Hospice
  • Ambulatory Surgical Centers

CMS states that the policies set out in the new FAQs are expected to be effective for the duration of the current Public Health Emergency, unless superseded by future legislation.

Written by:

Maynard Nexsen
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Maynard Nexsen on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide